CEO Yehiel Tal highlighted advancements in CollPlant's proprietary photocurable dermal filler, emphasizing its potential as a game-changer in the $6.3 billion market for aesthetic medicine.
When placing dental implants, practitioners should consider using Botox and dermal filler agents for patients who need facial volume restorations, according to a presentation at the American Academy ...
Evaluation of the stage IB designation of the 7th edition of the AJCC Staging System. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results